NVX
Novonix Limited [NVX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NVX Stock Summary
Top 10 Correlated Stocks
NVX
In the News
NVX Financial details
Company Rating
Sell
Market Cap
346.49M
Income
-84.87M
Revenue
11.81M
Book val./share
1.47
Cash/share
0.65
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
26 Aug 2024
P/E
-5.75
Forward P/E
-
PEG
-0.11
P/S
52.83
P/B
0.58
P/C
3.9
P/FCF
-3.2
Quick Ratio
17.74
Current Ratio
20.56
Debt / Equity
0.39
LT Debt / Equity
0.38
-
-
EPS (TTM)
-0.69
EPS next Y
-
EPS next Q
-
EPS this Y
245.45%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-2.44%
Revenue last 5Y
44.63%
Revenue Q/Q
7.12%
EPS Q/Q
-34.78%
-
-
-
-
SMA20
-
SMA50
50%
SMA100
50%
Inst Own
0.01%
Inst Trans
0.4%
ROA
-8%
ROE
-16%
ROC
-0.08%
Gross Margin
64%
Oper. Margin
-825%
Profit Margin
-873%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.4-3.59
52W High
-15.5%
52W Low
+153.5%
RSI
52
Rel Volume
0.14
Avg Volume
72.03K
Volume
10.22K
Perf Week
-4.7%
Perf Month
-0.59%
Perf Quarter
36.29%
Perf Half Y
48.25%
-
-
-
-
Beta
1.652
-
-
Volatility
0.19%, 0.22%
Prev Close
-1.36%
Price
2.535
Change
-2.5%
NVX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.08 | 0.04 | 0.01 | 0 | 0.07 | |
| Net income per share | -0.4 | -0.15 | -0.11 | 0 | -0.38 | |
| Operating cash flow per share | -0.11 | -0.07 | -0.06 | 0 | -0.3 | |
| Free cash flow per share | -0.22 | -0.28 | -0.24 | 0 | -0.45 | |
| Cash per share | 0.78 | 1.12 | 0.31 | 0 | 0.65 | |
| Book value per share | 1.35 | 1.51 | 0.54 | 0 | 1.51 | |
| Tangible book value per share | 0.97 | 1.38 | 0.51 | 0 | 1.41 | |
| Share holders equity per share | 1.35 | 1.51 | 0.54 | 0 | 1.51 | |
| Interest debt per share | 0.17 | 0.11 | 0.09 | 0 | 0.59 | |
| Market cap | 1.09B | 2.73B | 3.07B | 0 | 236.43M | |
| Enterprise value | 1.07B | 2.63B | 2.96B | -57.7M | 227.1M | |
| P/E ratio | -81.42 | -202.82 | -59.11 | 0 | -5.11 | |
| Price to sales ratio | 383.52 | 700.43 | 502.41 | 0 | 29.35 | |
| POCF ratio | -291.64 | -448.04 | -104.87 | 0 | -6.53 | |
| PFCF ratio | -147.4 | -105.93 | -27.12 | 0 | -4.27 | |
| P/B Ratio | 23.92 | 19.69 | 12.21 | 0 | 1.29 | |
| PTB ratio | 23.92 | 19.69 | 12.21 | 0 | 1.29 | |
| EV to sales | 375.4 | 676.72 | 485.95 | 0 | 28.2 | |
| Enterprise value over EBITDA | -111.06 | -264.12 | -68.54 | 0 | -5.44 | |
| EV to operating cash flow | -285.47 | -432.87 | -101.43 | 0 | -6.27 | |
| EV to free cash flow | -144.28 | -102.35 | -26.23 | 0 | -4.1 | |
| Earnings yield | -0.01 | 0 | -0.02 | 0 | -0.2 | |
| Free cash flow yield | -0.01 | -0.01 | -0.04 | 0 | -0.23 | |
| Debt to equity | 0.08 | 0.07 | 0.17 | 0.18 | 0.38 | |
| Debt to assets | 0.07 | 0.07 | 0.14 | 0.15 | 0.26 | |
| Net debt to EBITDA | 2.4 | 9.25 | 2.32 | 0 | 0.22 | |
| Current ratio | 10.33 | 26.9 | 20.56 | 13.72 | 11.37 | |
| Interest coverage | -4.59 | -79.91 | -32.33 | 0 | -16.34 | |
| Income quality | 0.28 | 0.45 | 0.56 | 0 | 0.78 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.43 | -0.8 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 3.33 | 3 | 6.53 | 0 | 5.57 | |
| Research and developement to revenue | 0 | 0 | 0.84 | 0 | 0.71 | |
| Intangibles to total assets | 0.24 | 0.08 | 0.04 | 0.04 | 0.05 | |
| Capex to operating cash flow | 0.98 | 3.23 | 2.87 | 0 | 0.53 | |
| Capex to revenue | -1.29 | -5.05 | -13.73 | 0 | -2.38 | |
| Capex to depreciation | -3.1 | -15.54 | -19.88 | 0 | -4.05 | |
| Stock based compensation to revenue | 1.78 | 1.15 | 2.41 | 0 | 0.7 | |
| Graham number | 3.46 | 2.24 | 1.17 | 0 | 3.59 | |
| ROIC | -0.25 | -0.07 | -0.17 | 0 | -0.18 | |
| Return on tangible assets | -0.34 | -0.1 | -0.18 | 0 | -0.18 | |
| Graham Net | 0.64 | 0.99 | 0.2 | 0 | 0.02 | |
| Working capital | 25.69M | 104.19M | 154.33M | 107.68M | 81.31M | |
| Tangible asset value | 33.1M | 126.09M | 238.77M | 213.88M | 171.95M | |
| Net current asset value | 22.45M | 94.34M | 110.38M | 64.78M | 9.75M | |
| Invested capital | 0.08 | 0.07 | 0.17 | 0.18 | 0.38 | |
| Average receivables | 661.02K | 1.19M | 1.99M | 2.65M | 3.21M | |
| Average payables | 749.16K | 976.43K | 2.01M | 3.38M | 2.73M | |
| Average inventory | 860.78K | 1.51M | 1.98M | 2.52M | 2.58M | |
| Days sales outstanding | 108.01 | 143.89 | 146.72 | 0 | 161.52 | |
| Days payables outstanding | 254.73 | 617 | 561.27 | 0 | 173.91 | |
| Days of inventory on hand | 410.77 | 940.57 | 396.23 | 0 | 259.22 | |
| Receivables turnover | 3.38 | 2.54 | 2.49 | 0 | 2.26 | |
| Payables turnover | 1.43 | 0.59 | 0.65 | 0 | 2.1 | |
| Inventory turnover | 0.89 | 0.39 | 0.92 | 0 | 1.41 | |
| ROE | -0.29 | -0.1 | -0.21 | 0 | -0.25 | |
| Capex per share | -0.11 | -0.21 | -0.18 | 0 | -0.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.01 | 0 | 0.03 | 0 | 0.03 | |
| Net income per share | -0.15 | 0 | -0.23 | 0 | -0.15 | |
| Operating cash flow per share | -0.16 | 0 | -0.17 | 0 | -0.13 | |
| Free cash flow per share | 0.08 | 0 | -0.28 | 0 | -0.18 | |
| Cash per share | 0.6 | 0 | 0.81 | 0 | 0.65 | |
| Book value per share | 1.23 | 0 | 1.66 | 0 | 1.47 | |
| Tangible book value per share | 1.1 | 0 | 1.56 | 0 | 1.37 | |
| Share holders equity per share | 1.23 | 0 | 1.66 | 0 | 1.47 | |
| Interest debt per share | 0.23 | 0 | 0.58 | 0 | 0.58 | |
| Market cap | 498.78M | 0 | 322.89M | 0 | 237.04M | |
| Enterprise value | 456.52M | 0 | 293.03M | 0 | 231.44M | |
| P/E ratio | -6.68 | 0 | -2.89 | 0 | -3.24 | |
| Price to sales ratio | 275.57 | 0 | 83 | 0 | 56.88 | |
| POCF ratio | -26.06 | 0 | -15.39 | 0 | -15.26 | |
| PFCF ratio | 51.11 | 0 | -9.47 | 0 | -10.89 | |
| P/B Ratio | 3.32 | 0 | 1.6 | 0 | 1.32 | |
| PTB ratio | 3.32 | 0 | 1.6 | 0 | 1.32 | |
| EV to sales | 252.22 | 0 | 75.33 | 0 | 55.54 | |
| Enterprise value over EBITDA | -26.19 | 0 | -11.28 | 0 | -14.77 | |
| EV to operating cash flow | -23.85 | 0 | -13.97 | 0 | -14.9 | |
| EV to free cash flow | 46.78 | 0 | -8.6 | 0 | -10.63 | |
| Earnings yield | -0.04 | 0 | -0.09 | 0 | -0.08 | |
| Free cash flow yield | 0.02 | 0 | -0.11 | 0 | -0.09 | |
| Debt to equity | 0.19 | 0 | 0.34 | 0 | 0.39 | |
| Debt to assets | 0.15 | 0 | 0.25 | 0 | 0.26 | |
| Net debt to EBITDA | 2.42 | 0 | 1.15 | 0 | 0.36 | |
| Current ratio | 13.72 | 0 | 17.45 | 0 | 11.37 | |
| Interest coverage | -30.31 | 0 | -29.06 | 0 | -9.53 | |
| Income quality | 1.03 | 0 | 0.75 | 0 | 0.85 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 19.23 | 0 | 3.78 | 0 | 0 | |
| Research and developement to revenue | 0.75 | 0 | 0.58 | 0 | 0.84 | |
| Intangibles to total assets | 0.09 | 0 | 0.04 | 0 | 0.05 | |
| Capex to operating cash flow | -1.51 | 0.55 | 0.62 | 0.45 | 0.4 | |
| Capex to revenue | 15.97 | 0 | -3.37 | 0 | -1.5 | |
| Capex to depreciation | 16.78 | 0 | -5.66 | 0 | -2.57 | |
| Stock based compensation to revenue | -2.79 | 0 | 1.75 | 0 | 0 | |
| Graham number | 2.06 | 0 | 2.92 | 0 | 2.22 | |
| ROIC | -0.1 | 0 | -0.1 | 0 | -0.07 | |
| Return on tangible assets | -0.11 | 0 | -0.1 | 0 | -0.07 | |
| Graham Net | 0.31 | 0 | 0.19 | 0 | -0.01 | |
| Working capital | 73.03M | 0 | 102.36M | 0 | 81.31M | |
| Tangible asset value | 133.86M | 0 | 189.87M | 0 | 167.42M | |
| Net current asset value | 40.86M | 0 | 29.64M | 0 | 5.22M | |
| Invested capital | 0.19 | 0 | 0.34 | 0 | 0.39 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 96.01 | 0 | 53.79 | 0 | 76.98 | |
| Days payables outstanding | 21.04 | 0 | 19.05 | 0 | 40.52 | |
| Days of inventory on hand | 16.21 | 0 | 11.17 | 0 | 14.08 | |
| Receivables turnover | 0.94 | 0 | 1.67 | 0 | 1.17 | |
| Payables turnover | 4.28 | 0 | 4.73 | 0 | 2.22 | |
| Inventory turnover | 5.55 | 0 | 8.06 | 0 | 6.39 | |
| ROE | -0.12 | 0 | -0.14 | 0 | -0.1 | |
| Capex per share | 0.24 | 0 | -0.11 | 0 | -0.05 |
NVX Frequently Asked Questions
What is Novonix Limited stock symbol ?
Novonix Limited is a AU stock , located in Brisbane of Qld and trading under the symbol NVX
What is Novonix Limited stock quote today ?
Novonix Limited stock price is $2.535 today.
Is Novonix Limited stock public?
Yes, Novonix Limited is a publicly traded company.
Company Profile
- Volume Average 72.03K
- Market Capitalization 346.49M
- CEO Dr. John Christopher Burns
- Headquarters Brisbane,QLD,AU
- IPO Date 2022-02-02
-
Website
https://www.novonixgroup.com 
Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. It operates through three segments: Graphite Exploration and Mining, Battery Technology, and Battery Materials. The Graphite Exploration and Mining segment explores for graphite in Australia. The Battery Technology segment develops battery cell testing equipment and batteries, and consulting services. The Battery Materials segment develops and manufactures battery anode materials. The company is also involved in the investment and battery testing activities. Novonix Limited has strategic alliance with Harper International Corporation to develop specialized furnace technology that would enhance Novonix's synthetic graphite manufacturing process; and partnership with Emera Technologies to develop and manufacture energy storage systems for community microgrids. The company was formerly known as Graphitecorp Limited and changed its name to Novonix Limited in July 2017. Novonix Limited was incorporated in 2012 and is headquartered in Brisbane, Australia.
